Paradigm Biocapital Advisors LP Vera Therapeutics, Inc. Transaction History
Paradigm Biocapital Advisors LP
- $2.77 Billion
- Q3 2024
A detailed history of Paradigm Biocapital Advisors LP transactions in Vera Therapeutics, Inc. stock. As of the latest transaction made, Paradigm Biocapital Advisors LP holds 1,096,851 shares of VERA stock, worth $50.7 Million. This represents 1.75% of its overall portfolio holdings.
Number of Shares
1,096,851Holding current value
$50.7 Million% of portfolio
1.75%Shares
1 transactions
Others Institutions Holding VERA
# of Institutions
184Shares Held
55.1MCall Options Held
134KPut Options Held
156K-
Avoro Capital Advisors LLC New York, NY4.31MShares$199 Million2.87% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.94MShares$182 Million0.02% of portfolio
-
Black Rock Inc. New York, NY3.34MShares$154 Million0.0% of portfolio
-
Abingworth LLP London, X02.96MShares$137 Million19.0% of portfolio
-
Sofinnova Investments, Inc. Menlo Park, CA2.79MShares$129 Million11.68% of portfolio
About Vera Therapeutics, Inc.
- Ticker VERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 27,042,300
- Market Cap $1.25B
- Description
- Vera Therapeutics, Inc., a clinical stage biotechnology company, focuses on developing and commercializing treatments for patients with serious immunological diseases in the United States. Its lead product candidate is atacicept, a fusion protein self-administered as a subcutaneous injection that is in Phase IIb clinical trial for patients with ...